Our Team

Ke Wang

Dr Ke Wang – Visiting Postdoc

Ke is a postdoctoral researcher in the Department of Infectious Diseases, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. He had received his PhD in Internal Medicine at Xi’an Jiaotong University in 2012 with Dr Yingren Zhao working on immune mechanism and therapy of viral hepatitis.

Ke completed his post-doctoral work at Sun Yat-sen University in 2014 with Dr Zhiliang Gao. He has been engaged in research related to immune mechanisms of hepatitis B virus infection.

Ke has joined our group as part of our collaboration with Professor Yuehua Huang’s group at the Third Affiliated Hospital of Sun Yat-sen University.

Ke’s Publications

Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure. Chen, T., Y. He, X. Liu, Z. Yan, K. Wang, H. Liu, S. Zhang and Y. Zhao (2012). Clin Exp Med 12(3): 159-164.
Promotion of hepatic differentiation of bone marrow mesenchymal stem cells on decellularized cell-deposited extracellular matrix. He, H., X. Liu, L. Peng, Z. Gao, Y. Ye, Y. Su, Q. Zhao, K. Wang, Y. Gong and F. He (2013). Biomed Res Int 2013: 406871.
Genome-wide histone 3 lysine 9 acetylation profiling in CD4+ T cells revealed endoplasmic reticulum stress deficiency in patients with acute-on-chronic liver failure. Jin, L., K. Wang, H. Liu, T. Chen, Y. Yang, X. Ma, J. Wang, Y. Li, D. Du, Y. Zhao and Y. He (2015). Scand J Immunol.
Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure. Lei, Z., Z. Mo, J. Zhu, X. Pang, X. Zheng, Z. Wu, K. Wang, X. Li, D. Xie and Z. Gao (2015). Mediators Inflamm 2015: 535938.
The distribution of HBV genotypes and clinical significance in familial clustering in an infected population with unfavorable prognosis. Liu, J., Y. Li, T. Chen, Y. Yang, K. Wang, Y. He, Q. Yang, F. Ye, Y. Jin, T. Qiu, S. Lin, M. Liu and Y. Zhao (2008). Arch Virol 153(11): 2157-2161.
Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure. Wang, K., H. Liu, Y. He, T. Chen, Y. Yang, Y. Niu, H. Chen, Y. Chen, J. Liu, F. Ye, S. Lin and Y. Zhao (2010). Hum Immunol 71(10): 950-956.
Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Wang, K., Z. B. Wu, Y. N. Ye, J. Liu, G. L. Zhang, Y. J. Su, H. L. He, Y. B. Zheng and Z. L. Gao (2014). Hepat Mon 14(7): e19370.
A New Biomarker for Hepatocellular Damage: Plasma Cell-Free DNA. Yan, Z., Y. He, Q. Li, M. Cui, K. Wang, T. Chen, H. Liu and Y. Zhao (2012). Advances in Anthropology 2: 214-220.
Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China. Yang, Y., L. Jin, Y. L. He, K. Wang, X. H. Ma, J. Wang, Z. Yan, Y. L. Feng, Y. Q. Li, T. Y. Chen, H. L. Liu and Y. R. Zhao (2013). J Med Virol 85(11): 1893-1899.

Bookmark the permalink.